Collins: “Not every one of these investigations is going to reveal something bad, but some of them will” April 26, 2019Vol.45 No.17
Conversation with The Cancer Letter NIH’s Lauer: “We have contacted over 55 institutions” April 26, 2019Vol.45 No.17By Paul Goldberg
Conversation with The Cancer Letter Pisters: “Trust is broken when a grant reviewer decides that an idea should be better done elsewhere” April 26, 2019Vol.45 No.17By Paul Goldberg
MD Anderson researchers ousted as NIH and FBI target diversion of intellectual property April 26, 2019Vol.45 No.17By Paul Goldberg
Drugs & Targets FDA expands pembrolizumab indication for first-line treatment of NSCLC April 12, 2019Vol.45 No.15
Drugs & Targets American Cancer Society study shows need to better identify who may not benefit from aggressive treatment April 12, 2019Vol.45 No.15
